PET-CT with Gallium 68 (DOTATATE) Doctors Abroad — Page 2

Professor Aksoy is an Assistant Professor at Cerrahpaşa Medical Faculty. He leads specialized imaging and interventional radiology services at Hisar Hospital Intercontinental.

• Expert in PET-CT with Gallium 68 diagnostics at a high-volume medical center
• Resident-trained at Istanbul University Cerrahpaşa Medical Faculty – a top Turkish institution
• Specializes in interventional radiology using imaging guidance for minimally invasive procedures
• Member of the European Society of Radiology which sets high imaging standards
• Presented academic research at 13 national and international medical congresses

Dr. Rahib Hasanov is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a prestigious observership program at Houston Methodist Hospital in Texas. Dr. Hasanov specializes in personalized oncology using immunotherapy and targeted therapies. He treats a wide range of conditions including gastrointestinal, breast, and lung cancers.

• Expertise includes targeted therapies and novel agents for stage 4 cancers.
• Treats complex urogenital system tumors, including prostate and ovarian cancers.
• Practices at JCI-accredited Hisar Hospital, a center treating 250,000 patients annually.
• Member of the Turkish medical community with international training in the US.

Professor Seref Komurcu is an ESMO-certified oncologist at Anadolu Medical Center. He specializes in treating neuroendocrine tumors that require PET-CT with Gallium 68 for staging.

• Authored over 110 scientific papers on cancer treatment
• Holds an ECFMG certificate from the United States
• Taught as a professor at Gulhane Military Medical Academy
• Treats neuroendocrine tumors of the pancreas and adrenal glands
• Member of the American Society of Clinical Oncology (ASCO)

Dr. Sezer Saglam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating gastrointestinal and breast cancers. His research on rectal cancer timing has influenced global treatment protocols. Dr. Saglam develops personalized therapy plans using targeted medicine and precision techniques.

• Nominated for the International Best Researcher Award for work on liver cancer.
• Leads clinical trials focused on targeted therapies and precision oncology.
• Member of the American Society of Clinical Oncology (ASCO).
• Certified by the European Society for Medical Oncology (ESMO).

Dr. Viola Fox is the Chief Physician at the Clinic for Oncology in Solingen. She is a leading expert in drug therapy for tumors in Germany and Europe. Dr. Fox holds a qualification in specialist genetics and conducts molecular biology research. She treats complex cases at a certified interdisciplinary cancer center.

• Member of the American Association for Cancer Research.
• Specializes in immunotherapy, targeted therapy, and molecular diagnostics.
• Treats hematological diseases, including lymphoma, leukemia, and myeloma.
• Works at Städtisches Klinikum Solingen, a clinic ranked among the top in Germany.

Professor Christoph Zielinski leads the Vienna Cancer Center. He uses PET-CT with Gallium 68 to guide personalized immunotherapy and targeted cancer treatments.

• Medical Director of the International Oncology Center at Wiener Privatklinik
• Authored over 600 scientific papers on oncology and tumor biology
• Former Head of Oncology at Vienna General Hospital
• Founder of the Comprehensive Cancer Center Vienna
• Member of the European Society for Medical Oncology

Professor Sebastian Keil serves as the Chief Physician for Diagnostic and Interventional Radiology at Academic Hospital Solingen. He specializes in using PET-CT with Gallium 68 to detect neuroendocrine tumors.

• Graduated with honors and holds a doctoral degree in radiology from Hamburg-Alton Clinic
• Trained under Prof. Rolf W. Günther, a world pioneer in interventional radiology techniques
• Performs high-precision cross-sectional imaging using CT and MRI for complex cancer cases
• Uses targeted imaging to guide minimally invasive treatments for liver and pancreatic tumors
• Former leading doctor at the Diagnostic and Interventional Radiology Clinic under Prof. Kuhl

Forbes Israel recognized Dr. Blachar Arye as one of the country's top physicians. This PET-CT specialist leads diagnostic imaging at Sourasky Medical Center.

• Fellowship trained in abdominal imaging at the University of Pittsburgh Medical Center
• Completed advanced CT colonography training at Harvard University and Beth-Israel-Deaconess Hospital
• Received the Magna Cum Lauda for research on liver transplant diagnostic imaging
• Elected Fellow of the European Society of Gastrointestinal and Abdominal Radiology
• Diagnostic radiology residency completed at Hadassah Medical Center

Professor Wolfgang Köstler is the Deputy Head of Oncology at the Medical University of Vienna. He uses advanced PET-CT with Gallium 68 to guide precision oncology and targeted therapies.

• Trained at Memorial Sloan-Kettering Cancer Center – a global leader in cancer care
• Specializes in molecular oncology to design treatments based on a patient's unique biology
• Senior Consultant at Wiener Privatklinik providing personalized systemic cancer treatments
• Holds a degree in molecular biology from the Weizmann Institute of Science
• Expert in treating complex gastrointestinal tumors and rare sarcomas

Professor Einat Even-sapir directs the Nuclear Medicine Department at Sourasky Medical Center. She specializes in using PET-CT with Gallium 68 to detect neuroendocrine tumors.

• Heads the nuclear medicine unit at Ichilov – one of Israel's largest hospitals
• Uses hybrid imaging – combines scanning types like PET and CT for higher accuracy
• Holds a PhD in medical sciences from the Israel Institute of Technology
• Completed specialized medical training at Dalhousie University in Canada
• Uses precision molecular imaging to identify small or hidden lesions

Dr. Atakan Topcu is a medical oncologist at Medipol Acibadem District Hospital in Istanbul. He specializes in treating solid tumors including lung, breast, and colorectal cancers. Dr. Topcu is an Associate Professor with over 50 peer-reviewed scientific publications. He sits on the Editorial Board of the medical journal BMC Cancer.

• Expertise in immunotherapy, targeted therapies, and geriatric oncology care.
• Treats cancer-related malnutrition, cachexia, and sarcopenia.
• Maintains active membership in the European Society for Medical Oncology (ESMO).
• Works at a JCI-accredited hospital specializing in advanced oncology treatments.

Dr. Gul Alco is a radiation oncologist and Professor at Medipol Acibadem District Hospital in Istanbul. She excels in treating complex cases, including stage 4 lung and liver cancers. Dr. Alco utilizes the CyberKnife and Da Vinci robotic systems for precise tumor targeting. She works at a JCI-accredited facility known for its high safety standards.

• Specializes in brachytherapy and high-intensity focused ultrasound ablation (HIFU).
• Performs radiofrequency ablation and proton-beam therapy for various malignancies.
• Treats pancreatic, breast, ovarian, and brain cancers using targeted radiation.
• Expert in nuclear medicine diagnostics, including PET-CT with Gallium 68.

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

Dr. Hasan Mutlu is a medical oncologist at Medical Park Antalya Hospital Complex. He specializes in immunotherapy, targeted cancer therapies, and genetic research in cancer treatment. Dr. Mutlu received his medical degree from Hacettepe University. He holds the title of Professor of Medicine. Dr. Mutlu focuses on organ tumor diagnosis and chemotherapy.

• Specializes in both medical and pediatric oncology cases.
• Treats complex conditions including neuroblastoma, Wilms tumor, and Ewing's sarcoma.
• Performs biological therapies and stays active in next-generation genetic research.
• Works at the Mediterranean region’s largest private hospital with PET-CT and LINAC technology.

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.

Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

• Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
• Authored over 40 research articles in journals indexed by SCI and SSCI.
• Completed dual fellowships in allergy-immunology and medical oncology.
• Treats complex sarcomas and renal cell carcinomas with systemic therapies.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Mesut Okur is a professor and chief physician at Medipol University Pendik Hospital in Istanbul. He specializes in pediatric health and diseases, with a focus on internal medical sciences. Dr. Okur has published over 25 international peer-reviewed articles. He treats children for conditions ranging from congenital heart defects to thyroid disorders.

• Published research on Down syndrome, pediatric brucellosis, and neonatal health.
• Supervises specialized medical theses on allergic rhinitis and pediatric diabetes.
• Practices at a hospital holding a Healthcare Quality Standards Certificate of 95.4%.
• Performed clinical research on pediatric voiding dysfunction and enuresis.